Age, mean ± SD years | 57.7 ± 15.4 |
Female sex, n (%) | 61 (61.0) |
Symptom duration, median (IQR) weeks | 12.0 (8.0 to 25.0) |
Fulfillment of ACR 1987 criteria for RA, n (%) | 81/97 (83.5) |
RF positive, n (%) | 61 (61.0) |
Anti-CCP positive, n (%) | 58/98 (59.2) |
DAS28, mean ± SD | 4.9 ± 1.1 |
No. of swollen joints (28 assessed), median (IQR) | 7.0 (4.0 to 12.0) |
No. of tender joints (28 assessed), median (IQR) | 4.0 (2.0 to 10.0) |
ESR, median (IQR) mm/hour | 31.2 ± 18.5 |
CRP, median (IQR) mg/litre | 11.5 (5.0 to 30.8) |
Patient's assessment of general health, mean ± SD (0 to 100 VAS) | 54.0 ± 22.5 |
Patient's assessment of pain, mean ± SD (0 to 100 VAS) | 51.7 ± 23.0 |
HAQ score, mean ± SD | 0.9 ± 0.7 |
SF-36 PCS score, mean ± SD | 38.3 ± 10.0 |
SF-36 MCS score, mean ± SD | 47.8 ± 12.6 |